What are the recommended intravenous and oral dosing regimens of sodium bicarbonate for adults with acute metabolic acidosis, for cardiac arrest, for children (≥1 year) and infants/neonates, and for chronic renal tubular acidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sodium Bicarbonate Dosing Recommendations

For pediatric patients with metabolic acidosis, hyperkalemia, or sodium channel blocker overdose, administer 1-2 mEq/kg IV/IO slowly; for adults in cardiac arrest with severe acidosis, give 50 mmol (50 mL of 8.4% solution) initially, repeating based on arterial blood gas results. 1, 2

Pediatric Dosing (Infants, Children ≥1 year)

Acute Metabolic Acidosis, Hyperkalemia, or Sodium Channel Blocker Overdose

  • IV/IO dose: 1-2 mEq/kg given slowly 1
  • Do NOT give by endotracheal route 1
  • For newborn infants: Use only 0.5 mEq/mL concentration; dilution of stock solutions may be necessary 1
  • Do not mix with vasoactive amines or calcium 1

Special Considerations for Sodium Channel Blocker Overdose (e.g., Tricyclic Antidepressants)

  • Titrate bicarbonate to maintain serum pH 7.45-7.55 1
  • Follow with infusion of 150 mEq NaHCO₃/L solution to maintain alkalosis 1
  • This is a Class 1 recommendation for adults and Class 2a for children 3

Critical Caveat for Cardiac Arrest

Routine initial use of sodium bicarbonate to treat cardiac arrest is NOT recommended 1, 4. However, it may be used in patients with documented metabolic acidosis ONLY after effective ventilation has been established (effective ventilation is needed to allow elimination of excess CO₂ produced by bicarbonate) 1. Recent evidence shows bicarbonate administration during pediatric cardiac arrest is associated with worse survival outcomes 5, 6, 5.

Adult Dosing

Cardiac Arrest with Severe Acidosis

  • Initial dose: 50 mmol (50 mL of 8.4% solution) 7, 2
  • May repeat every 5-10 minutes as indicated by arterial pH and blood gas monitoring 2
  • Use is limited to severe acidosis (arterial pH <7.1 and base excess <-10) 7
  • Special situations: cardiac arrest associated with hyperkalemia or tricyclic antidepressant overdose 7

Acute Metabolic Acidosis (Non-Arrest)

  • Initial dose: 1-2 mEq/kg (approximately 50-100 mEq for adults) over 4-8 hours 2
  • For less urgent metabolic acidosis: 2-5 mEq/kg over 4-8 hours depending on severity 2
  • Monitor with blood gases, plasma osmolarity, arterial lactate, hemodynamics, and cardiac rhythm 2

Important principle: Do NOT attempt full correction of low total CO₂ content during the first 24 hours 2. Target total CO₂ of approximately 20 mEq/L at end of first day, as achieving normal or above-normal values within the first day is very likely associated with grossly alkaline blood pH and undesired side effects 2.

Chronic Renal Tubular Acidosis/CKD

Oral Dosing for Chronic Metabolic Acidosis

  • Mean effective dose: approximately 1.1 mEq/kg/day 8
  • Target serum bicarbonate: minimum 22 mEq/L per clinical practice guidelines 9
  • Some evidence suggests targeting near 28 mEq/L may improve outcomes, though values >26 mEq/L have been associated with incident heart failure in observational studies 9
  • Treatment delays CKD progression and improves kidney and patient survival 8

Recent High-Quality Evidence Considerations

The most recent 2026 meta-analysis 10 of the BICAR-ICU trials (1,016 patients) provides crucial nuance:

  • Overall, sodium bicarbonate did NOT reduce 90-day mortality (RR 0.96,95% CI 0.86-1.07)
  • However, significant mortality benefit was seen in patients with pH ≤7.10 (RR 0.80,95% CI 0.68-0.93, p=0.004)
  • No benefit in patients with pH >7.10 (RR 1.05,95% CI 0.92-1.21)
  • Significantly reduced RRT initiation (34.8% vs 50.7%, NNT=6.3)

Another 2026 trial 11 (SODa-BIC, 500 patients) found no benefit for major adverse kidney events in critically ill patients with metabolic acidosis receiving vasopressors, though there was a trend toward less RRT use.

Key Clinical Pitfalls to Avoid

  1. Never give bicarbonate before establishing effective ventilation - the CO₂ produced must be eliminated 1
  2. Avoid rapid infusion - hypertonic solutions can cause undesirable rise in plasma sodium 2
  3. Do not over-correct in first 24 hours - risk of rebound alkalosis due to delayed ventilatory adjustment 2
  4. Check concentration for neonates - only 0.5 mEq/mL should be used 1
  5. Avoid mixing with calcium or vasoactive amines - incompatibility issues 1

References

Research

Approach to the Treatment of Chronic Metabolic Acidosis in CKD.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016

Related Questions

What is the evidence for using sodium bicarbonate in sepsis patients with severe metabolic acidosis (pH < 7.1) after adequate fluid resuscitation?
According to the 2026 guidelines, when and how should sodium bicarbonate be administered to adult patients with sepsis who develop severe metabolic acidosis (arterial pH ≤ 7.10) despite adequate fluid resuscitation and vasopressor therapy?
In a nursing‑home resident with severe metabolic acidosis who has been started on oral sodium bicarbonate, what follow‑up laboratory studies are recommended and how often should they be obtained?
How should intravenous sodium bicarbonate be dosed and administered to correct metabolic acidosis in an adult patient?
What are the recommended dosing regimens of sodium bicarbonate for adults and children in severe metabolic acidosis, cardiac arrest, and oral antacid use?
What is the diagnostic approach for polymyalgia rheumatica in a patient over 50 presenting with bilateral shoulder and hip girdle pain, morning stiffness >30 minutes, elevated erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP), normal creatine kinase, and rapid improvement with low‑dose prednisone?
What is the appropriate pre‑operative management for an elderly patient with type 2 diabetes mellitus on basal insulin glargine undergoing MRCP or surgery?
Can psychiatric medications cause pancytopenia?
Can a patient with coronary artery occlusion safely take Farxiga (dapagliflozin)?
How should fluoxetine be started, titrated, and monitored in an adult patient, including dosing adjustments for older adults and considerations during pregnancy or breastfeeding?
Can ziprasidone (Geodon) 40 mg or valproate (Depakote) 750 mg cause pancytopenia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.